 Shares of Ovid Therapeutics Inc NASDAQ:OVID shot up 35.7 on Thursday after Cantor Fitzgerald raised their price target on the stock from 7.00 to 13.00. Cantor Fitzgerald currently has an overweight rating on the stock. Ovid Therapeutics traded as high as 7.80 and last traded at 7.37, 12,706,107 shares were traded during trading. An increase ... 